Can a CBD cream soothe Eczema's relentless itch?
NCT ID NCT06994520
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This phase 2 trial is testing whether a 5% cannabidiol (CBD) cream can reduce itching and skin severity in adults with chronic eczema conditions like atopic dermatitis and nummular eczema. About 60 participants will apply the CBD cream or a standard steroid cream for 4 weeks. The study measures changes in itch intensity and skin signs like redness and scaling, aiming to see if CBD offers a safer long-term option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a 5% cannabidiol (CBD) cream
- What this could lead to
- If effective, this could offer a new, non-steroid option for managing chronic eczema itch and skin inflammation.
- What could go wrong
- This is a small, early-stage trial, so results may not apply broadly. CBD creams can cause skin irritation, and the effect may be no better than standard treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Khon Kaen University
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm severe eczema when creams fall short?
- Can a new biologic calm severe eczema?
- Can a daily probiotic soothe colicky babies and calm eczema?
- Can a new injection match an existing eczema treatment?
- Can Real-World data unlock better skin disease care?
- Can a meditation app soothe teen eczema?